Evidence map›Paper›PMID 36555277›Full record

ArticleInternational journal of molecular sciences2022

Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma.

Valerija Begić, Petra Korać, Slavko Gašparov, Marija Rozman, Petra Simicic, Snjezana Zidovec-Lepej

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Valerija BegićDivision of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0002-6031-404X
Petra KoraćDivision of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0003-4783-2114
Slavko GašparovInstitute of Clinical Pathology and Cytology, Merkur University Hospital, 10000 Zagreb, Croatia.
Marija RozmanDepartment of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
Petra SimicicDepartment of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
Snjezana Zidovec-LepejDepartment of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.ORCID 0000-0001-9852-5806
University Hospital Centre Zagreb · HRUniversity of Zagreb · HR

Funding

Croatian Science Foundation IP-2020-02-8961
6 · The paper itself

Abstract

Hodgkin lymphomas (HLs) are a heterogeneous group of lymphoid neoplasia associated with Epstein-Barr virus (EBV) infection. EBV, considered to be an important etiological co-factor in approximately 1% of human malignancies, can be classified into two genotypes based on EBNA-2, EBNA-3A and EBNA-3C sequences, and into genetic variants based on the sequence variation of the gene coding for the LMP1 protein. Here, we present the results on the distribution of EBV genotypes 1 and 2 as well as

Indexed as

Epstein-Barr Virus InfectionsHodgkin DiseaseAntigens, ViralEpstein-Barr Virus Nuclear AntigensHerpesvirus 4, HumanHumansViral Matrix ProteinsAntigens, ViralEpstein-Barr Virus Nuclear AntigensViral Matrix ProteinsEBVgenotypingHodgkin’s lymphomaLMP1

Identifiers

PMID36555277
PMCPMC9778902
OpenAlexW4312123480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.